Insulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular Factors
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Degludec; Drug: Glargine U300 Sponsors: University of Split, School of Medicine; Pavle Vrebalov Cindro; Jonatan Vuković; Darko Modun; Božo Smajić; Gordan Kardum; Tina Tičinović Kurir; Doris Rušić; Ana Šešelja Perišin; Josipa Bukić Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials